In one of our previous studies in mouse lung cancer models, we found that the treatment with a CD26 inhibitor suppresses lung metastases and primary lung cancer growth by attenuating EMT and enhancing tumor-infiltrating NK cells (12, 13). This evidence concerns the gene DPP4 and neoplasm.